期刊文献+

线性超滤模式联合左卡尼汀对维持性血液透析低血压的疗效观察 被引量:2

The efficacy observation of linear ultrafiltration mode combined with levocarnitine on maintenancehemodialysis hypotension
下载PDF
导出
摘要 目的探讨线性超滤模式联合左卡尼汀对维持性血液透析低血压的疗效。方法将本院收治的64例维持性血液透析患者随机分为对照组和观察组,两组均在线性超滤模式下透析,仅观察组加用左卡尼汀。分析两组治疗前、治疗1、6个月的血压指标(透析前血压和透析中的最低血压)并记录低血压和不良反应的发生率。结果治疗1个月后,观察组的最低血压高于治疗前,低血压及不良反应率均低于治疗前;治疗6个月后,两组的以上指标均优于治疗前,差异有统计学意义。观察组治疗1、6个月的透析中最低血压均高于对照组,除治疗6个月的收缩压(P<0.01),治疗1个月后的不良反应发生率低于对照组(P<0.05)。结论线性超滤模式联合左卡尼汀对维持性血液透析低血压的治疗和预防效果均较好,不仅提高透析中最低血压,而且还可降低低血压及不良反应发生率。 Objective To explore the effecacy of linear ultrafiltration mode combined with levocarnitine on maintenance hemodialysis hypotension. Methods 64 patients on maintenance hemodialysis admitted by our hospital from January to December 2011 were randomly divided into control group and observation group. Both groups underwent dialysis under linear uhrafihration mode, and only the observation group was given levocarnitine additionally. The iollowing indices were compared between two groups, such as blood pressure parameters( predialysis blood pressure and dialysis hypotension)and rate of hypotension and ad- verse reaction. Results The dialysis hypotension values in observation group of 1 st and 6th month post-treatment were higher than those of Control group, and despite the systolic blood pressure of 6th month post-treatment (P 〈 0. 01 ), the rest were P 〈 0. 05. The rates of hypotension in observation group was lower than Control group as well as the adverse reaction 1st month post-treatment ( P 〈 0. 05 ). Conclusion The effecacy of linear uhrafiltration mode combined with levocarnitine on maintenance hemodialysis hy- potension is better.
出处 《四川医学》 CAS 2013年第3期399-401,共3页 Sichuan Medical Journal
关键词 线性超滤模式 左卡尼汀 维持性血液透析低血压 疗效 linear ultrafiltration mode levocarnitine maintenance hemodialysis hypotension clinical effect
  • 相关文献

参考文献3

二级参考文献41

  • 1刘虹,刘伏友,彭佑铭,朱健玲,李军,陈星.可调钠血液透析对透析低血压的预防作用[J].中国血液净化,2002,1(8):21-23. 被引量:123
  • 2汤学宇,吴冬英,陈燕芳,熊勇,赵中苏,谢吉玉,李维.高钙透析液对透析中低血压患者血压的影响[J].中国血液净化,2004,3(10):558-559. 被引量:13
  • 3俞海瑾,陈楠.透析相关低血压[M]//梅长林,叶朝阳,戎殳.实用透析手册.2版.北京:人民卫生出版社,2009:340.
  • 4Calvani M, Benatti P, Mancinelli A, et al. Camitine replacement in end-stage renal disease and hemodialysis[ J]. Ann N Y Acad Sci, 200,*, 1033:52 - 66.
  • 5Schindler R. Causes and therapy of microinflammation in renal fail- ure[ J ]. Nephrol Dial Transplant,2004,19 ( suppl 5 ) :34 - 40.
  • 6Johannes D, Dirk K, Martin B, et al. Ultrafiltration pro- filing and measurement of relative blood volume as strategies to reduce dialysis-related ideeffects[J]. Am J Kidney Dis,2000,36(1) :115-123.
  • 7Jean G. Clinical assessment of continuous dialysate os- molality and ultrafiltration control in hemodialysis by seven different profiles [J]. Nephrol Dial Transplant, 1996,11:2 374-2 375.
  • 8Nicholas M Setby, Christopher W, McIntyre. A sys- tematic review of the clinical effects of reducing dialy- sate fluid temperature [J]. Nephrol Dial Transplant, 2006,21:1 883-1 898.
  • 9Selby NM, Mclntyre CW. A systematic review of the clinical effects of reducing dialysate fluid temperature [J].Nephrol Dial Transplant,2006,21 :1 883-1 898.
  • 10蒙兰芬.低温、可调钠与超滤模式透析对预防透析相关性低血压的作用[J].广西医科大学学报,2007,24(5):741-742. 被引量:11

共引文献38

同被引文献13

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部